How to manage CVD risk in PCa patients during COVID-19

Moderator(s)
Prof. P-A. Abrahamsson (SE)
Presenter(s)
Prof. P-A. Abrahamsson (SE)
Prof. A.K. Ghosh (GB)
Prof. M. Linch (GB)
Dr. R.A. Rendon (CA)
Prof. Dr. M.J. Ribal Caparros (ES)
Date & time
Wednesday, 7 April 2021, 18:30 - 19:30 CEST
 
 
 
 
 

How do you manage CVD risk in PCa patients during COVID-19?
What's in store for you in Module 2?

Look forward to the following presentations by renowned experts in their respective fields:

Moderator: P-A. Abrahamsson (SE)

Impact of COVID-19 on cardio-oncology
By Prof. Arjun Ghosh (GB), cardio-oncologist

COVID-19 Recommendations for Prostate Cancer treatment by the EAU Guidelines
By Prof. Dr. Maria Ribal (ES), urologist

How to manage prostate cancer in a pandemic
By Dr. Ricardo Rendon (CA), urologic oncologist

Hormonal treatment of urological cancers during COVID-19
By Prof. Mark Linch (GB), oncologist 

This online curriculum is developed by the Canadian Urological Association (CUA), the International Cardio-Oncology Society (ICOS), and the European Association of Urology (EAU) and combines quality scientific content with current evidence-based recommendations and real-life clinical practice experience. 

At a glance
Publication date: April 2021
Available languages: English
Topic: Prostate cancer
CME: This webinar is accredited with 1 European CME credit (ECMEC®) upon completion of the questionnaire after attending the live webinar
Duration: Approx. 60 minutes

This educational activity has been funded by Ferring. The educational programme of this online activity has been a collaboration with Ferring, but independently developed and approved by the Canadian Urological Association, the International Cardio-Oncology Society together with the European Association of Urology.

Registration for this webinar is now closed

The recording will be available at www.uroweb.org/webinars 24 hours after the webinar has taken place.

Back to UROwebinar overview
Contact information
European Association of Urology
Registrations department
+31 (0)26 389 1751